Piper Sandler Maintains Overweight on ICU Medical, Raises Price Target to $195
Piper Sandler analyst Jason Bednar maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $163 to $195.
Read original at benzingaStocks · News reference
ICU Medical Q2 Adj. EPS $2.37 Beats $1.91 Estimate, Sales $551.700M Beat $533.428M Estimate
ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $2.37 per share which beat the analyst consensus estimate of $1.91 by 24.08 percent. This is a 12.86 percent increase over earnings of $2.10 per share from the
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 6, 2026, 8:07 PM
- Checked
- Aug 6, 2026, 8:07 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
ICU Medical shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance above estimates. Also, BTIG and Needham raised their respective price targets on the stock
Read original at benzingaICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings
ICU Medical Inc (NASDAQ:ICUI) reported strong Q2 earnings of $2.37 per share and raised its FY2026 guidance. Analysts have increased price targets for the stock.
Read original at benzingaBTIG Maintains Buy on ICU Medical, Raises Price Target to $200
BTIG analyst Sam Eiber maintains ICU Medical (NASDAQ:ICUI) with a Buy and raises the price target from $170 to $200.
Read original at benzinga